CLN3 is required for the clearance of glycerophosphodiesters from lysosomesNouf N. Laqtom, Monther Abu-Remaileh, Christian Grimm et al.|Nature|2022Cited by 139
Glycerophosphodiesters inhibit lysosomal phospholipid catabolism in Batten diseaseKwamina Nyame, Monther Abu-Remaileh, Andy Hims et al.|Molecular Cell|2024Cited by 36
Cell-Type Resolved Protein Atlas of Brain Lysosomes Identifies SLC45A1-Associated Disease as a Lysosomal DisorderAli Ghoochani, Monther Abu-Remaileh, Julia C. Heiby et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 11
Cell-type resolved protein atlas of brain lysosomes identifies SLC45A1-associated disease as a lysosomal disorderAli Ghoochani, Abu-Remaileh Monther, Julia C. Heiby et al.|Cell|2026Cited by 4
Suppressing the Migration of Human Breast Cancer Cell Line by Targeting VAMP3 with miR-199a-3pNouf N. Laqtom, Khloud Algothmi|Journal of King Abdulaziz University-Medical Sciences|2016Cited by 0